Future multicenter, longitudinal studies incorporating inflammatory and nutritional markers are needed to validate these associations, explore mechanistic pathways, and clarify whether ERFE and hepcidin could serve as diagnostic or therapeutic targets in the management of CKD-related anemia. The gene discussed is HAMP; the disease is anemia (phenotype).